{"name":"Pulmotect, Inc.","slug":"pulmotect-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPTWpXc3VzY3BHVkgtSzBYbE4zc2Rkenc4ZGNYUUZCenVDaEVXdGtYT1pEVWlsWjNmQnplMjNPQjdsaVRhOFdQUDN1eUdUTFQwZUxfOUIwa2NZdFJhZk5lQXZ0ZWpmQzkwY3lLb1dtSnQ2dGlWamJ2NTFhckFreFZNbmtyLXJ2T3lPeG0yMENQOFgxdEhobklMU2VHOVBLYUNyX01iVjRyOVdRZTM2WDB6MncwUk96aUM2TElVRmVDSWFpaTBIU1pXQWJWNUJCcXlsTHBwYmJXdUNDYVFPT09TeVBEaW1HZ0xqMG1MdlgxcF9YTVBRVEIyR3d3anRnTUptcGhsQktRazlzNk9HTmtTV2ZNMGNxOEw3QTR6QThFbDZUazBOekJlRlRmV3Z0b2h4ckdnYnlqMDFvU25rVVdRV1ZTaTFJVl9aZFdzOUEyM3M?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene","headline":"COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxQblQ2eEttMko4Zk1MM0JDdjNXTURkeXRzLTdfLUVxVy1BQmZqZlNkbXd2cVViSDhiX2dybXE0UldoSHdEbjNTa2pwNF9xeWdFMWlSbzlZUEd6RGJ1SHM2OVVWUEpOeG1nbG9vdFlmalp1YzZNd29uT2R6eTZnZkJSbkJ3bmc0Zi1SdEE5OVA5TGlCc2VmSjM4bHV1enJFUFpFY2RsdmJ0dkJxVFJELXcyMDN1bUNaOU1KSHp2cjJKUEwySWxLYWZSWnM0WWxMZDVzSTdOOU15X3BTSUVNVFpEc2FYU1VfQVQ3RjhUcVpPUkprLU1haGkzN291M3JKMTNKNXloU1lZemtFaTh2R1J0VlNTZ0J0U25EQU91QTVsUGc?oc=5","date":"2026-04-07","type":"trial","source":"Business Upturn","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight - Business Upturn","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQQ1RoLWM1Skk4Y2xOUUo1eDJkNFJhZWRZV2N0eEZmV2hfci1uS2tvVjRiNTV1TUVrWGVBMXZzc2J0dnpQS0xma0dKZ0lUUThZRzd6ZTJZZHUzVF85SE5VcGlrdG5iWUVpRHZrUEdrYkJGZURZQ2IwRl9TOHZwLVdVQ0NXc2R3dnRxUDdIcllNaC14RjBRZEg3MmQ0aHlhNllSbkVaSC12Vld5eU9ZX2NnNnhJdlRJamhiaXNZMHFMNmdkcE1rMlVzRkxRaUo5enhJbUtvTFBJTzN1WkxtUC03elZnUWllTlQ1QnE3YkNVNjd6WlZiSnZLWnIwSWRPdnpnYTAwUUJrbUlndy1hSlZlTGJ4ZEZtRnBIMVRMMFpR?oc=5","date":"2026-03-30","type":"trial","source":"Barchart.com","summary":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Chronic Obstructive Pulmonary Disease Clinical Trial Pipeline Appears Robust With 65+ Key Pharma Companies Actively Work","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxObHRZbW5qbUhROVktVlZwYWNoYjRlVEtjME5JVzlWRzFqdlhpLXljMk5BWmRqNXZXbmhpTFpHWlR1QmYtbm5WVEJwQ0xfaVFrTnhvRGNNMnkteHpmRGVvTTNYSnRjY3ZFa0QtLXVSX1Q3VFJLOUFtUTRQTTdhX3ZfWHJ5ZlIwRldIT1VpaER0ZndiekZ0akJvOFZPNFlfb21fU1pFQ0pwNVJqdXRNZVRKTDVCQnZJXy1VVWFTQlE0S0ZzVjRKdW1IVWx3WTdJSERaNzk3alM3Zk53Mmd5QWpRcEQzcEdJWVJ0RktSalJXUGRtZk9reGVTbnhkMmo0SlE?oc=5","date":"2024-08-07","type":"pipeline","source":"globenewswire.com","summary":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight - globenewswire.com","headline":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9WNlhES3ZfTmktdWthR1NvNW9ONU5PdnJmUFhpSUZMNnhZcVk1anhMQjJiSi1mRXpkWGQ0WS1ZeERFbUduV0ZyQ1FfSTZNNEFPMTlyRDlmTEMxZ2h2LUxubTNYZWxoMVZGdjF2bU13R2x3OXNjUE1XWGJuSQ?oc=5","date":"2024-06-19","type":"pipeline","source":"Wiley","summary":"NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage - Wiley","headline":"NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOdDFoRm5ZVDQ5b29KVnVtanFVT09PQVlYN21HSjQxb1RPRTZULW5fSkhmVHJocGdNZjNaLU1XN1B5cXVxT3l1UGhiMUhRUUZDWEd4TjhEX3RpQ3ZRejJLall6SXVSaFZfVXBUTHMyR3Z4elN2OGZCdFphYV9STHdVdlNZZXFVOWpqT2IySEV5eVRZY2VBYlJHb05B?oc=5","date":"2023-06-13","type":"pipeline","source":"InnovationMap","summary":"Seattle biotech co. to move to Houston thanks to $13.3M grant from Texas organization - InnovationMap","headline":"Seattle biotech co. to move to Houston thanks to $13.3M grant from Texas organization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQeGdQdDdJMVpoZEE5Z2VTQnRIdk9BMHpHOFZDQnVmOEtQemtIbjdkaTBTRjdEMmRKNG40RU1ZOEQ2MjBBeXktTnZSQ3VZbVM0WDJSVV9YM3E5UWtPdUN2R0t3dTVmU2NvX2d5M1J1ODVIcDZIWTk3LXVKdHU2YWZyUjIyQnBDUWJSMVZxdHFLWDQ3MEk2RkpUTmZrNDBsMXBkV1phZjhJY3ZJcGJuNzgyWFV2Nlp1YXM4cEN1R1VtUnYxRVZfNkdXbnM2UEhEdw?oc=5","date":"2020-05-07","type":"trial","source":"PR Newswire","summary":"PARI Nebulizer Used in New Study with Pulmotect's Inhaled PUL-042 for COVID-19 - PR Newswire","headline":"PARI Nebulizer Used in New Study with Pulmotect's Inhaled PUL-042 for COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdUE1SWpjNXhOTldNY0ZUSklqeWdFWlM4bmlnTDRPV3kzaWoxbzZYZjE5RmJmUXpyUDJ4eUc5dlhPWnp1ams2ODJVeE1iRzNSX2ZGcHJrdVVYcjJfTm5teWplM2taQ0hWN1UxWFlkbGtTbzBjM3h2cVk5RDg5ekJkTzVMeGUxbUQzeXZrLTk3SjdCdVFCOVJiZFJjeXFjbHc?oc=5","date":"2019-10-16","type":"pipeline","source":"InnovationMap","summary":"Houston biopharmaceutical company brings on new CEO to grow company - InnovationMap","headline":"Houston biopharmaceutical company brings on new CEO to grow company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}